sc002 and Glioma
sc002 has been researched along with Glioma* in 1 studies
Other Studies
1 other study(ies) available for sc002 and Glioma
| Article | Year |
|---|---|
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.
Isocitrate dehydrogenase (. We evaluated. Compared to. DLL3 is selectively and homogeneously expressed in Topics: Antibodies, Monoclonal, Humanized; Benzodiazepinones; Brain; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genotype; Glioma; Humans; Immunoconjugates; Intracellular Signaling Peptides and Proteins; Isocitrate Dehydrogenase; Ligands; Male; Membrane Proteins; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Receptors, Notch; RNA | 2019 |